| Net Cash Provided by (Used in) Operating Activities |
$3,118,966 |
USD |
-205% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,675,396 |
USD |
28% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,872,054 |
USD |
-19% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,922,308 |
USD |
-1060% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$10,979,924 |
USD |
92% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$2,059,757 |
USD |
21% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$45,911,000 |
USD |
2.9% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$62,488,000 |
USD |
-1.9% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$3,277,000 |
USD |
0% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$180,837 |
USD |
-54% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$54,575,000 |
USD |
-1.5% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$329,815,150 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$18,075 |
USD |
-5.5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$16,577,000 |
USD |
-13% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$7,260,000 |
USD |
-1.3% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |